Regarding fondaparinux, which of the following choices represents the correct route of administration and the correct indication of use?
A. PO route, for stroke prevention in atrial fibrillation
B. Subcutaneous route, for DVT prophylaxis/treatment and hip/knee replacement surgeries
C. Intravenous route, for the treatment of hemorrhagic stroke
D. Subcutaneous route, for the prevention of stroke in atrial fibrillation
E. Intravenous route, for the treatment of heparin-induced thrombocytopenia